3rd Quarter - Report

PRIME POLICY GROUP for KEDRION BIOPHARMA

Firm
Client
Income
$200,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Pharmaceutical tariffs; regulatory issues

Foreign entity interest: Pharmaceutical tariffs

LobbyistCovered position, as disclosed
CASIE ELIZABETH DAUGHERTY —
MARK DISLER —

Contacted: SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.